Surprising news from Flowr Corp looks bad, but could signal a turnaround in cannabis stocks is near.
The U.S. market for CBD-based products COULD reach $6 billion by 2025. Is the FDA about to get out of the way?
There is majority bipartisan support to legalize cannabis. But three Senate Republicans stand in the way.
MediPharm Labs and Valens GroWorks are the two leaders in Canadian cannabis extraction. MediPharm MIGHT be the best value for investors at present.
Cannabis Concentrates are the New Frontier, and this infographic from Ionic Brands highlights how consumers are significantly shaping the landscape of cannabis.
The phony concern from Health Canada and the mainstream media regarding CannTrust's cultivation lapse does not stand up to scrutiny.